Core Insights - Ionis Pharmaceuticals announced that its experimental drug for brain disorders successfully met the primary endpoint in an early-to-late-stage clinical study [1] Company Summary - Ionis Pharmaceuticals is advancing its drug development for brain disorders, indicating progress in clinical trials [1]